ArticleHeliyon2025
The incidence and influencing factors of hypertensive disorders during pregnancy in hangzhou, China, between 2012 and 2021.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Temporal Patterns in Preterm Birth Subtypes and Perinatal Survival, 2000-2023: Population-Based, Repeated Cross-Sectional Time-Series.BJOG : an international journal of obstetrics and gynaecology · 2026Article
- Assessment of the Burden of Maternal Hypertensive Disorders and the Quality of Care in China: A Systematic Analysis of the Global Burden of Disease (GBD) 2021 Study.International journal of women's health · 2026Article
- Impact of Maternal Overweight and Obesity on Pregnancy Outcomes Following Cesarean Delivery: A Retrospective Cohort Study.Healthcare (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze the incidence and influencing factors of hypertensive disorders of pregnancy (HDP) in Hangzhou, China, between 2012 and 2021. Methods: We conducted a retrospective cohort study to analyze data relating to 155,433 pregnant women in Hangzhou, China, who were divided into eight groups: gestational hypertension (GH, 4247 cases), preeclampsia (PE, 1602 cases), severe preeclampsia (SPE, 995 cases), eclampsia (9 cases), HELLP syndrome (43 cases), chronic hypertension (43 cases), chronic hypertension combined with PE or SPE (77 cases), postpartum eclampsia (5 cases), and pregnant women with normal blood pressure (148412 cases). Odds ratios (ORs) and 95 % confidence intervals (95 % CIs) were used to show the association of factors with HDP. Results: The total incidence of HDP was 45.17 ‰ (95 % CI: 44.14‰-46.20 ‰), and the subtypes of HDP showed an increasing trend from 2012 to 2021 (all Conclusions: The incidence of HDP and its subtypes showed an overall increasing trend from 2012 to 2021. Maternal factors and pregnancy outcomes may be strongly associated with HDP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.